Novartis
The Principal Scientist, Early Pipeline Development role focuses on developing state-of-the-art downstream purification processes for next-generation AAV gene therapy. This position involves executing early-stage process development to assess the developability of AAV gene therapy lead candidates and creating new platform processes for existing and novel AAV capsids and cargo vectors. The role requires leading a downstream process team and collaborating with cross-functional teams to advance pipeline programs into clinical phases.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Scientist, Downstream Process Scale-Up
Sanofi
Advisor, Downstream Process Development – Viral Vectors
Eli Lilly and Company
Scientist - Viral Vector Downstream Process Development
Eurofins
Associate Scientist I
Forge Biologics
Senior Research Engineer
Leica Biosystems
Postdoctoral Fellow in Pediatrics
PeopleAdmin